Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung Cancer.

Ham, Ahrong; Lee, Young; Kim, Hae Su; Lim, Taekyu

Ham, Ahrong; Lee, Young; Kim, Hae Su; Lim, Taekyu.

Afiliação

Ham A; Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Medical Center, Ewha Womans University College of Medicine, Seoul 07985, Republic of Korea.
Lee Y; Division of Hematology-Oncology, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul 05368, Republic of Korea.
Kim HS; Veterans Medical Research Institute, Veterans Health Service Medical Center, Seoul 05368, Republic of Korea.
Lim T; Division of Hematology-Oncology, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul 05368, Republic of Korea.

Cancers (Basel) ; 15(16)2023 Aug 21.

Article em En | MEDLINE | ID: mdl-37627226

Palavras-chave

immune checkpoint inhibitor; immunotherapy; non-small-cell lung cancer; older patients; real-world data

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google